id
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2023-12-25 03:14:22
expired found date
-
created at
2024-06-28 00:17:06
updated at
2026-01-05 09:53:04
length
17
crc
14235
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
171878
mp size raw text
28303
mp inner links count
70
mp inner links status
20 (imported)
title
PHARMAnetwork magazine - world pharmaceutical & CDMO business news
description
PHARMAnetwork magazine offers authoritative insight on world pharmaceutical CDMO news and analysis on themes: outsourcing, CDMO, contract pharma, strategy, finance, regulatory, innovation, manufacturi
site name
author
© 1998 - 2020 PHARMAnetwork
updated
2026-01-02 12:37:20
raw text
PHARMAnetwork - pharmaceutical CDMO business and contract pharma news - PHARMAnetwork magazine Menu Latest Magazine Editorial line Current Edition Browse all editions Web edition Apps editions Topics Video Webinars WhitePapers Events About us Contact us Advertise with us Keep up with PHARMAnetwork Linkdin Twitter WORLD PHARMACEUTICAL & CDMO BUSINESS NEWS Last news analysis Exclusive strategic alliance between Recipharm and Exela By Editors - 02 October 2024 Recipharm and Exela Pharma Sciences, a US-based client-centric CDMO, are announced their exclusive strategic alliance aimed at enhancing sterile manufacturing capabilities in the United States. ... Read... The weight-loss drug marquet is shaking up the global CDMO landscape By Editors - 6 February 2024 The dramatic growth of glucagon-like peptide (GLP-1)-based therapies has accelerated over the past 18 months, primarily driven by broader use for the treatme...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Medicine [en] (226)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
21770
text words
3903
text unique words
1217
text lines
624
text sentences
204
text paragraphs
68
text words per sentence
19
text matched phrases
16
text matched dictionaries
11
links self subdomains
0
links other subdomains
0
links other domains
34 - pharmanetwork.digital, vetter-pharma.com, recipharm.com, terrapinn.com, cphi.com, formu-tech.com, pda.org, poddconference.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
links ext klim
0
links ext generic
0
dol status
0
dol updated
2026-01-02 12:37:20
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
1 (priority 1 already searched, no matches found)
sitemap review version
2
sitemap urls count
0
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
-
sitemap process date
-
sitemap first import date
-
sitemap last import date
-